NORepinephrine Bitartrate Injection (Pharmedium) – Subpotent Drug (2019)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
NORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00 mL Viaflex Bag, High Alert, Rx Only, PharMEDium Services LLC., 12620 W Airport Blvd #130 Sugar Land, TX 77478.
Brand
Pharmedium Services, LLC
Lot Codes / Batch Numbers
Lot #s: 192930039S Exp. 12/18/19, 192930041S Exp. 12/18/19, 192940048S Exp. 12/19/19, 192940049S Exp. 12/19/19, 192950031S Exp. 12/20/19, 192950032S Exp. 12/20/19, 192960039S Exp. 12/22/19, 192960040S Exp. 12/22/19, 192960041S Exp. 12/22/19, 192960042S Exp. 12/22/19, 192970034S Exp. 12/22/19, 192970036S Exp. 12/22/19, 192970037S Exp. 12/22/19, 192980043S Exp. 12/25/19, 192980044S Exp. 12/25/19, 192980045S Exp. 12/25/19, 193010042S Exp. 12/26/19, 193020042S Exp. 12/27/19, 193030039S Exp. 12/28/19, 193030040S Exp. 12/28/19, 193030049S Exp. 12/28/19, 193040045S Exp. 12/29/19, 193040046S Exp. 12/29/19, 193040047S Exp. 12/29/19, 193080040S Exp. 1/2/20, 193080041S Exp. 1/2/20, 193080042S Exp. 1/2/20, 193080043S Exp. 1/2/20, 193080044S Exp. 1/2/20, 193090034S Exp. 1/3/20, 193090035S Exp. 1/3/20, 193090036S Exp. 1/3/20, 193100041S Exp. 1/4/20, 193100042S Exp. 1/4/20, 193100043S Exp. 1/4/20, 193120036S Exp. 1/8/20, 193150028S Exp. 1/9/20, 193170033S Exp. 1/11/20, 193170034S Exp. 1/11/20, 193170035S Exp. 1/11/20, 193180035S Exp. 1/12/20, 193190035S Exp. 1/15/20, 193190038S Exp. 1/15/20, 193220038S Exp. 1/16/20, 193230037S Exp. 1/17/20, 193240029S Exp. 1/18/20, 193240030S Exp. 1/18/20, 193240031S Exp. 1/18/20, 193250028S Exp. 1/19/20, 193360031S Exp. 1/30/20
Products Sold
Lot #s: 192930039S Exp. 12/18/19; 192930041S Exp. 12/18/19; 192940048S Exp. 12/19/19; 192940049S Exp. 12/19/19; 192950031S Exp. 12/20/19; 192950032S Exp. 12/20/19; 192960039S Exp. 12/22/19; 192960040S Exp. 12/22/19; 192960041S Exp. 12/22/19; 192960042S Exp. 12/22/19; 192970034S Exp. 12/22/19; 192970036S Exp. 12/22/19; 192970037S Exp. 12/22/19; 192980043S Exp. 12/25/19; 192980044S Exp. 12/25/19; 192980045S Exp. 12/25/19; 193010042S Exp. 12/26/19; 193020042S Exp. 12/27/19; 193030039S Exp. 12/28/19; 193030040S Exp. 12/28/19; 193030049S Exp. 12/28/19; 193040045S Exp. 12/29/19; 193040046S Exp. 12/29/19; 193040047S Exp. 12/29/19; 193080040S Exp. 1/2/20; 193080041S Exp. 1/2/20; 193080042S Exp. 1/2/20; 193080043S Exp. 1/2/20; 193080044S Exp. 1/2/20; 193090034S Exp. 1/3/20; 193090035S Exp. 1/3/20; 193090036S Exp. 1/3/20; 193100041S Exp. 1/4/20; 193100042S Exp. 1/4/20; 193100043S Exp. 1/4/20; 193120036S Exp. 1/8/20; 193150028S Exp. 1/9/20; 193170033S Exp. 1/11/20; 193170034S Exp. 1/11/20; 193170035S Exp. 1/11/20; 193180035S Exp. 1/12/20; 193190035S Exp. 1/15/20; 193190038S Exp. 1/15/20; 193220038S Exp. 1/16/20; 193230037S Exp. 1/17/20; 193240029S Exp. 1/18/20; 193240030S Exp. 1/18/20; 193240031S Exp. 1/18/20; 193250028S Exp. 1/19/20; 193360031S Exp. 1/30/20
Pharmedium Services, LLC is recalling NORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volum due to Subpotent Drug. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Subpotent Drug
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026